Scientific

[ad_1] At Johns Hopkins University, Diane Griffin is the Distinguished Service Professor, a professor of Medicine and Neurology at the School of Medicine, and the W. Harry Feinstone professor at the Department of Molecular Microbiology and Immunology at the Bloomberg School of Public Health. She has also been vice president of the U.S. National Academy of
[ad_1] SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the establishment of its Cell Therapy Scientific Advisory Board (SAB). The Cell Therapy SAB is comprised of industry and academic leaders in the cell therapy field, covering
[ad_1] Herantis Pharma Plc, Press Release, 25 October 2021 at 9:00 EEST Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies for debilitating neurodegenerative diseases, today announced the formation of a Scientific Advisory Board (SAB) comprised of industry leaders in CNS and neurodegenerative diseases, chaired by Dr. Anders Gersel Pedersen (as announcment September 14, 2021).
[ad_1] LOWELL, Mass., Oct. 14, 2021 /PRNewswire/ — Versatope Therapeutics Incorporated, a biotechnology company developing vaccines and immuno-therapeutics, announced today that Dr. Drew Weissman, a leading mRNA vaccine expert, joined their Scientific Advisory Board. Separately, Dr. James Kuo and Jeremy Gowler joined the company’s Board of Directors to diversify their pipeline and expand their business
[ad_1] SHANGHAI & SUZHOU, China–(BUSINESS WIRE)–EpimAb Biotherapeutics, a clinical stage biotech company specializing in bispecific antibodies, today announced the appointment of Andrew X. Zhu, M.D., Ph.D., to the company’s Scientific Advisory Board. Dr. Zhu is internationally recognized as a leading authority in hepatocellular carcinoma and cholangiocarcinoma and brings decades of research and clinical expertise. He
[ad_1] – Philippe Vandeput appointed as Chief Business Officer and Rakesh Dixit joins the company’s Scientific Advisory Board (SAB) – AYE, Belgium, October 05, 2021–(BUSINESS WIRE)–atbtherapeutics today announced the appointments of Philippe Vandeput as Chief Business Officer (CBO) and Rakesh Dixit, PhD, as a member of its Scientific Advisory Board (SAB). Mr. Vandeput and Dr.